Abstract:The use of intracellular reductive microenvironment to control the release of therapeutic payloads has emerged as a popular approach to design and fabricate intelligent nanocarriers. However, these reduction-responsive nanocarriers are generally trapped within endolysosomes after internalization and are subjected to unwanted disintegration, remarkably compromising the therapeutic performance. Herein, amphiphilic polyprodrugs of poly(N,N-dimethylacrylamide-co-EoS)-b-PCPTM were synthesized via sequential reversible addition-fragmentation chain transfer (RAFT) polymerization, where EoS and CPTM are Eosin Y- and camptothecin (CPT)-based monomers, respectively. An oil-in-water (O/W) emulsion method was applied to self-assemble the amphiphilic polyprodrugs into hybrid vesicles in the presence of hydrophobic oleic acid (OA)-stabilized upconversion nanoparticles (UCNPs, NaYF4:Yb/Er), rendering it possible to activate the EoS photosensitizer under a near-infrared (NIR) laser irradiation with the generation of singlet oxygen (1O2) through the energy transfer between UCNPs and EoS moieties. Notably, the in situ generated singlet oxygen (1O2) can not only exert its photodynamic therapy (PDT) effect but also disrupt the membranes of endolysosomes and thus facilitate the endosomal escape of internalized nanocarriers (i.e., photochemical internalization (PCI)). Cell experiments revealed that the hybrid vesicles could be facilely taken up by endocytosis. Although the internalized hybrid vesicles were initially trapped within endolysosomes, a remarkable endosomal escape into the cytoplasm was observed under 980 nm laser irradiation as a result of the PCI effect of 1O2. The escaped hybrid vesicles subsequently underwent GSH-triggered CPT release in the cytosol, thereby activating the chemotherapy process. The integration of PDT module into the design of reduction-responsive nanocarriers provides a feasible approach to enhance the therapeutic performance.

Construction of Reduction-Responsive Photosensitizers Based on Amphiphilic Block Copolymers and Their Application for Photodynamic Therapy

Porphyrin-containing amphiphilic block copolymers for photodynamic therapy

Redox-responsive supramolecular amphiphiles constructed via host-guest interactions for photodynamic therapy

Photodynamic Therapy of Oligoethylene Glycol Dendronized Reduction-Sensitive Porphyrins

Triple-Function Porphyrin in Glycopolymeric Photosensitizer: From PhotoATRP to Targeted PDT

Ultrasensitive Redox-Responsive Porphyrin-Based Polymeric Nanoparticles for Enhanced Photodynamic Therapy

RAFT Synthesis and Characterization of Poly(Butyl-co-2-(N,N-Dimethylamino)Ethyl Acrylates)-block-Poly(Polyethylene Glycol Monomethyl Ether Acrylate) as a Photosensitizer Carrier for Photodynamic Therapy

Doxorubicin-loaded redox-responsive amphiphilic dendritic porphyrin conjugates for chemotherapy and photodynamic therapy

N-Methylpyridylporphyrin Tailed with Folate Conjugate As a Potential Lysosomal-Targeted Photosensitizer: Synthesis, DNA Interaction, Singlet Oxygen and Subcellular Localization

Photosensitizer with High Efficiency Generated in Cells via Light‐Induced Self‐Oligomerization of 4,6‐Dibromothieno[3,4‐ b ]thiophene Compound Entailing a Triphenyl Phosphonium Group

Near-Infrared Light-Activated Photochemical Internalization of Reduction-Responsive Polyprodrug Vesicles for Synergistic Photodynamic Therapy and Chemotherapy.

Pillar[5]arene-Based Switched Supramolecular Photosensitizer for Self-Amplified and pH-Activated Photodynamic Therapy

A Sequential Dual‐Model Strategy Based on Photoactivatable Metallopolymer for On‐Demand Release of Photosensitizers and Anticancer Drugs

A red-light-activated sulfonamide porphycene for highly efficient photodynamic therapy against hypoxic tumor

Photocontrollable release and enhancement of photodynamic therapy based on host–guest supramolecular amphiphiles

Activatable Photosensitizer for Smart Photodynamic Therapy Triggered by Reactive Oxygen Species in Tumor Cells

Amphiphilic Protoporphyrin IX Derivatives as New Photosensitizing Agents for the Improvement of Photodynamic Therapy

A Self‐Degradable Conjugated Polymer for Photodynamic Therapy with Reliable Postoperative Safety

Metabolizable Photosensitizer with Aggregation-Induced Emission for Photodynamic Therapy

pH-Responsive self-assembled polymer-photosensitizer conjugate for activable photodynamic therapy

Combining Multiple Photosensitizer Modules into One Supramolecular System for Synergetic Enhancement of Photodynamic Therapy